The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback